GO:2000050 regulation of non-canonical Wnt signaling pathway: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000050 describes any process that modulates the frequency, rate or extent of non-canonical Wnt signaling, the beta-catenin-independent branch of Wnt signaling.
• Non-canonical Wnt signaling controls planar cell polarity, morphogenetic movements during gastrulation and neural tube closure, and stem cell fate decisions.
• Key regulators include WNT5A, WNT11, FZD2, FZD7, ROR1, ROR2, RYK, DVL, and downstream effectors such as RHOA and JNK.
• Dysregulation of non-canonical Wnt signaling is implicated in cancer, fibrosis, circadian disruption-driven tumorigenesis, and developmental defects.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of non-canonical Wnt regulators in relevant cell types.
• EDITGENE provides end-to-end CRISPR cell model generation and CRISPR library screening to study GO:2000050-related genes at scale.
Description
GO:2000050, regulation of non-canonical Wnt signaling pathway, is a biological process term that encompasses any process modulating the frequency, rate or extent of non-canonical Wnt signaling. Non-canonical Wnt signaling refers to beta-catenin-independent Wnt pathways, including the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway, which are distinct from the canonical beta-catenin-dependent route. This regulatory term is critical because the balance between canonical and non-canonical Wnt signaling determines cell polarity, migration, differentiation, and tissue homeostasis. Researchers study GO:2000050 to understand how cells interpret Wnt cues during development and disease, and to identify therapeutic targets in cancer, fibrosis, and developmental disorders. The term is defined in QuickGO as any process that modulates the frequency, rate or extent of non-canonical Wnt signaling pathway, with synonyms including regulation of beta-catenin-independent Wnt receptor signaling pathway and regulation of non-canonical Wnt receptor signaling pathway.
regulation of non-canonical Wnt signaling pathway At A Glance
| GO ID | GO:2000050 |
|---|---|
| GO term | regulation of non-canonical Wnt signaling pathway |
| Ontology | biological_process |
| Synonym | regulation of beta-catenin-independent Wnt receptor signaling pathway; regulation of non-canonical Wnt-activated signaling pathway; regulation of non-canonical Wnt receptor signaling pathway; regulation of non-canonical Wnt receptor signalling pathway |
| Major function | Modulates the frequency, rate or extent of non-canonical Wnt signaling, which controls cell polarity, migration, and differentiation independently of beta-catenin. |
| Key ligands | WNT5A, WNT11, and other non-canonical Wnt ligands. |
| Key receptors | FZD2, FZD7, ROR1, ROR2, RYK. |
| Downstream effectors | DVL, RHOA, JNK, and calcium signaling components. |
| Associated diseases | Cancer, fibrosis, developmental defects, and circadian disruption-induced tumorigenesis. |
What Is GO:2000050?
In our own words, GO:2000050 represents the regulatory control points that tune the activity, duration, or intensity of Wnt signaling that does not rely on beta-catenin stabilization. This includes modulation of ligand-receptor interactions, intracellular signal transduction, and feedback mechanisms that specifically affect non-canonical branches such as the planar cell polarity pathway and the Wnt/Ca2+ pathway.
Why Is regulation of non-canonical Wnt signaling pathway Important in Cell Biology?
Understanding GO:2000050 is essential because non-canonical Wnt signaling regulates fundamental processes such as gastrulation, neural tube closure, and stem cell maintenance, and its dysregulation contributes to cancer progression, fibrosis, and developmental abnormalities. The regulatory mechanisms that control this pathway are therefore attractive targets for therapeutic intervention and for interpreting disease-associated genetic variants.
• Controls morphogenetic movements during gastrulation and neural tube closure.
• Regulates planar cell polarity and cytoskeletal organization.
• Modulates stem cell self-renewal and differentiation.
• Implicated in circadian disruption-induced mammary tumorigenesis.
• Alters Meckel's cartilage morphology when dlx5a/dlx6a locus is lost.
• Associated with adrenocortical carcinoma progression and metastasis.
• Plays roles in immune cell function and inflammation.
• Orchestrates lung development and fibrosis through Fzd2.
• Provides targets for cancer therapy and fibrosis intervention.
• Enables CRISPR-based functional genomics of non-canonical Wnt regulators.
What Happens During regulation of non-canonical Wnt signaling pathway?
Ligand-receptor recognition and selectivity
In simple terms: Specific Wnt proteins bind to specific receptors on the cell surface to start non-canonical signaling.
Non-canonical Wnt signaling is initiated when ligands such as WNT5A and WNT11 bind to receptors including FZD2, FZD7, ROR1, ROR2, and RYK. The regulation of this step determines which pathway is activated, as Fzd2 can orchestrate both canonical and non-canonical outputs depending on context. This selectivity is crucial for processes like lung development and fibrosis.
Intracellular signal transduction and effector activation
In simple terms: Inside the cell, the signal is passed to proteins that change cell shape and gene expression.
Upon receptor activation, Dishevelled (DVL) is recruited and activates downstream effectors such as RHOA and JNK, leading to cytoskeletal rearrangements and transcriptional changes. The Wnt/Ca2+ branch triggers calcium release and activation of calcium-dependent enzymes. These events are tightly regulated to ensure appropriate cellular responses during development and tissue homeostasis.
Feedback and crosstalk with canonical Wnt signaling
In simple terms: The non-canonical pathway can turn itself off or interfere with the canonical pathway.
Regulation of non-canonical Wnt signaling includes negative feedback loops and crosstalk with beta-catenin-dependent signaling. For example, Fzd2 modulates both canonical and non-canonical arms, and imbalance can lead to fibrosis. Such crosstalk is essential for fine-tuning cellular responses to Wnt ligands.
Integration with developmental and homeostatic programs
In simple terms: The pathway is connected to larger programs that control embryo development and tissue maintenance.
Non-canonical Wnt signaling is integrated with morphogenetic movements during gastrulation and neural tube closure, and with stem cell fate decisions. Loss of dlx5a/dlx6a alters non-canonical Wnt signaling and affects Meckel's cartilage morphology, demonstrating its role in craniofacial development. In cancer, circadian disruption can hijack non-canonical WNT signaling to promote mammary tumorigenesis.
Key Genes Involved in GO:2000050 regulation of non-canonical Wnt signaling pathway
The following genes and proteins are central to the regulation of non-canonical Wnt signaling pathway (GO:2000050).
| Gene | Major Role | Research Relevance |
|---|---|---|
| WNT5A | Non-canonical ligand that activates beta-catenin-independent signaling | Implicated in cancer, inflammation, and developmental processes |
| WNT11 | Ligand that promotes planar cell polarity and morphogenetic movements | Studied in gastrulation and neural tube closure |
| FZD2 | Receptor that orchestrates canonical and non-canonical Wnt signaling | Key regulator of lung development and fibrosis |
| FZD7 | Receptor involved in non-canonical Wnt signaling | Roles in stem cell maintenance and cancer |
| ROR1 | Receptor tyrosine kinase that mediates non-canonical Wnt signaling | Target in cancer and immune regulation |
| ROR2 | Receptor tyrosine kinase critical for planar cell polarity | Mutations cause developmental disorders |
| RYK | Atypical receptor that interacts with Wnt ligands | Regulates axon guidance and cell migration |
| DVL | Scaffold protein that transduces non-canonical Wnt signals | Central node for pathway regulation |
| RHOA | Small GTPase that controls cytoskeletal dynamics downstream of non-canonical Wnt | Mediates cell polarity and migration |
| JNK | Kinase activated by non-canonical Wnt signaling | Regulates transcription and apoptosis |
| LILRB4 | Immune receptor that regulates non-canonical WNT signaling in tumorigenesis | Links circadian disruption to mammary cancer |
| DLX5A | Transcription factor affecting non-canonical Wnt signaling | Loss alters Meckel's cartilage morphology |
| DLX6A | Transcription factor affecting non-canonical Wnt signaling | Loss alters Meckel's cartilage morphology |
| CTNNB1 | Beta-catenin, canonical Wnt effector; crosstalk with non-canonical pathway | Context-dependent interactions |
| WNT3A | Canonical Wnt ligand; can influence non-canonical signaling via crosstalk | Used to study pathway specificity |
| VANGL2 | Core planar cell polarity protein | Regulates non-canonical Wnt/PCP signaling |
| CELSR1 | Adhesion GPCR involved in planar cell polarity | Modulates non-canonical Wnt signaling |
How Is regulation of non-canonical Wnt signaling pathway Regulated?
Regulation of non-canonical Wnt signaling is achieved through multiple mechanisms, including ligand availability, receptor expression levels, and intracellular feedback loops. Crosstalk with canonical Wnt signaling, as seen with Fzd2, can shift the balance between pathways. Additionally, circadian disruption can modulate non-canonical WNT signaling via LILRB4, linking environmental factors to pathway activity. Post-translational modifications and protein-protein interactions further fine-tune signal strength and duration.
regulation of non-canonical Wnt signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LILRB4 | Circadian disruption-induced mammary tumorigenesis | Knockout or overexpression in mammary epithelial cells |
| FZD2 | Lung fibrosis and developmental defects | Knockout or knock-in in lung fibroblasts or epithelial cells |
| DLX5A/DLX6A | Meckel's cartilage malformation | Knockout in zebrafish or mouse models |
| WNT5A | Cancer progression and inflammation | Point mutation or overexpression in cancer cell lines |
| ROR2 | Developmental disorders and cancer | Knockout or point mutation in stem cells |
Cancer
Dysregulated non-canonical Wnt signaling contributes to tumorigenesis and metastasis. LILRB4 regulates circadian disruption-induced mammary tumorigenesis via non-canonical WNT signaling. In adrenocortical carcinoma, non-canonical Wnt signaling is associated with stemness and metastatic progression. Targeting this pathway is a potential therapeutic strategy.
Fibrosis
Fzd2 orchestrates canonical and non-canonical Wnt signaling to regulate lung development and fibrosis, suggesting that modulation of non-canonical signaling could impact fibrotic diseases.
Developmental disorders
Non-canonical Wnt signaling controls morphogenetic movements during gastrulation and neural tube closure, and its disruption can lead to developmental defects. Loss of dlx5a/dlx6a alters non-canonical Wnt signaling and Meckel's cartilage morphology, highlighting its role in craniofacial development.
Immune regulation
Non-canonical Wnt signaling operates in immune cells, influencing inflammation and immune responses, which has implications for autoimmune diseases and cancer immunotherapy.
From regulation of non-canonical Wnt signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene alter non-canonical Wnt signaling? | CRISPR knockout cell line (e.g., HEK293, cancer cells) |
| Does a specific point mutation in a receptor affect pathway activity? | CRISPR point mutation knock-in |
| Does tagging an effector protein reveal its localization? | Knock-in of fluorescent tag (e.g., GFP) |
| Does overexpression of a ligand drive non-canonical signaling? | CRISPR overexpression (e.g., CRISPRa) |
| Which genes regulate non-canonical Wnt signaling in a genome-wide manner? | CRISPR library screening |
| How does a disease-associated variant affect pathway function? | Knock-in of variant allele in isogenic cell lines |
How to Study the regulation of non-canonical Wnt signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes | Identify downstream targets of non-canonical Wnt |
| Proteomics | Protein expression and modifications | Discover effectors and feedback regulators |
| Immunofluorescence | Protein localization and cell polarity | Visualize PCP components |
| Luciferase reporter | Pathway activity | Quantify non-canonical Wnt signaling |
| Western blot | Phosphorylation of JNK, RHOA activation | Measure pathway activation |
| CRISPR knockout screen | Gene essentiality for pathway activity | Identify novel regulators |
| CRISPR activation screen | Gain-of-function effects | Find activators of non-canonical Wnt |
| Live-cell imaging | Dynamic cytoskeletal changes | Study cell migration and polarity |
Transcriptomic and proteomic profiling
RNA-seq and proteomics can identify global changes in gene and protein expression upon modulation of non-canonical Wnt signaling. These methods help uncover downstream effectors and feedback regulators.
Imaging and cell polarity assays
Live-cell imaging and immunofluorescence can visualize cytoskeletal rearrangements and planar cell polarity establishment, which are hallmarks of non-canonical Wnt activation.
Reporter assays and biochemical readouts
Luciferase reporters for non-canonical pathways (e.g., AP-1, NFAT) and immunoblotting for phosphorylated JNK or RHOA activation provide quantitative measures of pathway activity.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify novel regulators of non-canonical Wnt signaling, accelerating target discovery.
How CRISPR Can Be Used to Study GO:2000050 regulation of non-canonical Wnt signaling pathway
Knockout
CRISPR knockout of candidate genes (e.g., WNT5A, FZD2, ROR2) can determine whether they are required for non-canonical Wnt signaling. This approach is widely used in cancer and developmental biology.
Point Mutation
Introducing specific point mutations (e.g., in FZD2 or ROR2) via CRISPR can mimic disease-associated variants and reveal their impact on pathway regulation.
Knock-in
Knock-in of tags (e.g., GFP) or reporter cassettes allows tracking of protein localization and pathway activity in live cells.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can drive non-canonical Wnt signaling to study gain-of-function effects and identify downstream consequences.
How EDITGENE Supports regulation of non-canonical Wnt signaling pathway Research
Researchers studying regulation of non-canonical Wnt signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway modulation or is merely correlated with changes in expression. EDITGENE provides the tools to establish causality through precise genome editing and functional screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of non-canonical Wnt signaling pathway research.
Frequently Asked Questions About regulation of non-canonical Wnt signaling pathway
What is GO:2000050?
GO:2000050 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of non-canonical Wnt signaling pathway, which is beta-catenin-independent.
What genes are involved in regulation of non-canonical Wnt signaling pathway?
Key genes include WNT5A, WNT11, FZD2, FZD7, ROR1, ROR2, RYK, DVL, RHOA, and JNK, among others.
What is the difference between canonical and non-canonical Wnt signaling?
Canonical Wnt signaling depends on beta-catenin stabilization, while non-canonical signaling is beta-catenin-independent and includes planar cell polarity and Wnt/Ca2+ pathways.
How is non-canonical Wnt signaling regulated?
It is regulated by ligand availability, receptor expression, feedback loops, and crosstalk with canonical Wnt signaling.
What diseases are associated with non-canonical Wnt signaling?
It is implicated in cancer, fibrosis, developmental disorders, and immune dysregulation.
What research methods are used to study GO:2000050?
Common methods include RNA-seq, proteomics, imaging, reporter assays, and CRISPR screens.
How can CRISPR help study regulation of non-canonical Wnt signaling?
CRISPR knockout, point mutation, knock-in, and overexpression enable causal testing of gene function in pathway regulation.
What is the role of FZD2 in non-canonical Wnt signaling?
FZD2 orchestrates both canonical and non-canonical Wnt signaling to regulate lung development and fibrosis.
Is non-canonical Wnt signaling involved in cancer?
Yes, it contributes to tumorigenesis, metastasis, and stemness in various cancers, including mammary and adrenocortical carcinomas.
How does LILRB4 regulate non-canonical WNT signaling?
LILRB4 regulates circadian disruption-induced mammary tumorigenesis via non-canonical WNT signaling pathway.
Conclusion
GO:2000050, regulation of non-canonical Wnt signaling pathway, is a critical biological process that controls cell polarity, migration, and differentiation through beta-catenin-independent mechanisms. Its dysregulation is linked to cancer, fibrosis, and developmental defects, making it a rich area for therapeutic targeting. Advances in CRISPR genome editing and functional genomics now allow researchers to dissect the regulatory networks of this pathway with unprecedented precision, accelerating the translation of basic findings into clinical applications.
References
- 1. Hu L et al.. 2024. Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease.. Bone Res 12(1):39 PMID: 38987555
- 2. Shi DL. 2022. Wnt/planar cell polarity signaling controls morphogenetic movements of gastrulation and neural tube closure.. Cell Mol Life Sci 79(12):586 PMID: 36369349
- 3. Sarabia-Sánchez MA et al.. 2024. WNT Signaling in Stem Cells: A Look into the Non-Canonical Pathway.. Stem Cell Rev Rep 20(1):52-66 PMID: 37804416
- 4. Ogunlusi O et al.. 2025. LILRB4 regulates circadian disruption-induced mammary tumorigenesis via non-canonical WNT signaling pathway.. Oncogene 44(46):4491-4504 PMID: 41102383
- 5. Yu EPY et al.. 2023. Loss of dlx5a/dlx6a Locus Alters Non-Canonical Wnt Signaling and Meckel's Cartilage Morphology.. Biomolecules 13(9) PMID: 37759750
- 6. Shapiro I et al.. 2025. (Non)canonical Wnt signaling, cytoarchitecture and stemness: new insights from primary nonmetastatic, primary metastatic, regional and distant metastatic models of adrenocortical carcinoma.. Exp Mol Med 57(11):2657-2670 PMID: 41310103
- 7. Chae WJ et al.. 2018. Canonical and Non-Canonical Wnt Signaling in Immune Cells.. Trends Immunol 39(10):830-847 PMID: 30213499
- 8. Zhou J et al.. 2025. Fzd2 orchestrates canonical and non-canonical Wnt signaling to regulate lung development and fibrosis.. Cell Commun Signal 23(1):498 PMID: 41257888
